Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism

Transplantation

Volumn 81, Issue 12, 2006, Pages 1708-1715

  Holáň, Vladimír ^a,b   Pindjáková, Jana ^a   Krulová, Magdaléna ^a   Neuwirth, Aleš ^a   Frič, Jan ^a   Zajícová, Alena ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Arginase; CD4+ T cells; Macrophages; Nitric oxide; Skin grafts

Indexed keywords

ARGINASE; ARGININE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 4; N(G) HYDROXYARGININE; NITRIC OXIDE; VALINE;

ADOLESCENT; ALLOGRAFT; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; GENE OVEREXPRESSION; GRAFT REJECTION; ISOGRAFT; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SKIN GRAFT; TH1 CELL; TH2 CELL; XENOGRAFT;

ANIMALS; ARGINASE; ARGININE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT REJECTION; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES; MALE; MICE; NITRIC OXIDE; RATS; SKIN; SKIN TRANSPLANTATION; TH1 CELLS; TH2 CELLS; TISSUE CULTURE TECHNIQUES; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33745449514     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000226067.89690.2b     Document Type: Article

References (41)

1. Lancaster JRJ, Langrehr JM, Bergonia HA, et al. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992; 257: 10994.
2. Ioannidis I, Hellinger A, Dehmlow C, et al. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 1995; 59: 1293.
3. Stevens RB, Ansite JD, Mills CD, et al. Nitric oxide mediates early dysfunction of rat and mouse islets after transplantation. Transplantation 1996; 61: 1740.
4. Szabolcs MJ, Ravalli S, Minanov O, et al. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998; 65: 804.
5. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 63.
6. Krulová M, Zajícová A, Frǐc J, Holáň V. Alloantigen-induced, T cell-dependent production of nitric oxide by macrophages infiltrating skin allografts. Transplant Int 2002; 15: 108.
7. Roza AM, Cooper M, Pieper G, et al. NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance. Transplantation 2000; 69: 227.
8. Bronte V, Serafini P, Mazzoni A, et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. TRENDS Immunol 2003; 24: 302.
9. Salimunddin, Nagasaki A, Gotoh T, et al. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol Endocrinol Metab 1999; 277: E110.
10. Noel W, Hassanzadeh G, Raes G, et al. Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and susceptible mice. Infect Immun 2002; 70: 6180.
11. Duley S, Vincendeau P, Courtois P, et al. Mouse strain susceptibility to Trypanosome infection: an arginase-dependent effect. J Immunol 2004; 172: 6298.
12. Iniesta V, Gómez-Nieto LC, Corraliza I. The inhibition of arginase by N-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001; 193: 777.
13. Bruch-Gerharz D, Schnorr O, Suschek C, at al. Arginase 1 overexpression in psoriasis: limitation ol inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 2003; 162: 203.
14. Morris CR, Poljakovic M, Lavrisha L, et al. Decreased arginine bioavailability and increased serum arginase activity in ashma. Am J Respir Crit Care Med 2004; 170: 148.
15. Barksdale AR, Bernard AC, Maley ME, et al. Regulation of arginase expression by T-helper II cytokines and isoproterenol. Surgery 2004; 135: 527.
16. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992; 54: 326.
17. Strom TB, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688.
18. Morris CF, Simeonovic CJ, Fung MC, et al. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 1995; 154: 2470.
19. Singh NP, Guo L, Mhoyan A, Shirwan H. Predominant expression of Th2 cytokines and interferon-γ in xenogeneic cardiac grafts undergoing acute vascular rejection. Transplantation 2003; 75: 586.
20. Holáň V, Pindjáková J, Zajícová A, et al. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells. Xenotransplantation 2005; 12: 227.
21. Billingham RE, Brent L, Medawar PB, Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proc R Soc Lond B Biol Sci 1954; 143: 43.
22. Dialynas DP, Wilde DB, Marrack P, et al. Characterization of the murine antigenic determinant designed L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T-cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983; 74: 29.
23. Ohara J, Paul WE. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 1985; 315: 333.
24. Holáň V, Sedláčková K, Ružičková M. Production of high levels of Th1 and Th2 cytokines in mice with acquired transplantation tolerance. Cell Immunol 1996; 174: 7.
25. + T cells. J Immunol 1998; 161: 3237.
26. 15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131.
27. Corralisa IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994; 174: 231.
28. Wren SM, Wang SC, Thai NL, et al. Evidence for early Th2 T cell predominance in xenoreactivity. Transplantation 1993; 56: 905.
29. Witte MB, Barbul A, Schick MA, et al. Upregulation of arginase expression in wound-derived fibroblasts. J Surg Res 2002; 195: 35.
30. Louis CA, Mody V, Henry WL Jr., et al. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol 1999; 363: R237.
31. + T cells correlates with Th1/Th2 phenotype. J Immunol 1998; 160: 5347.
32. Li J, Hunter CA, Farrell JP. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J Immunol 1999; 162: 974.
33. Louis CA, Reichner JS, Henry WL Jr., et al. Distinct arginase isoforms expressed in primary and transformed macrophages: Regulation by oxygen tension. Am J Physiol 1998; 274: R775.
34. Vockley JG, Jenkinson CP, Shikla H, et al. Cloning and characterization of the human type II arginase gene. Genomics 1996; 38: 118.
35. Munder M, Mollinedo F, Calafat J, et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2004; 105: 2549.
36. ω-hydroxy-L- arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun 1994; 203: 1614.
37. Morris SM, Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002; 22: 87.
38. Iyer R, Jenkinson CP, Vockley IG, et al. The human arginases and arginase deficiency. J Inherit Metab Dis 1998; 21: 86.
39. Morris SM, Jr. Regulation of arginase availability and its impact on NO synthesis. In: Nitric Oxide. Biology and Pathobiology. Ignarro LJ, ed. San Diego: Academic Press, 2000: 187.
40. Szabo C, Southan GJ, Wood E, et al. Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement for a serum factor. Br J Pharmacol 1994; 112: 355.
41. Simeonovic CI, Cordery DV, Van Leeuwen B, et al. Host systemic and local nitric oxide levels do not correlate with rejection of pig proislet xenografts in mice. Xenotransplantation 2002; 9: 169.